BR112021023832A8 - Métodos e composições para geração de óxido nítrico e usos dos mesmos - Google Patents
Métodos e composições para geração de óxido nítrico e usos dos mesmosInfo
- Publication number
- BR112021023832A8 BR112021023832A8 BR112021023832A BR112021023832A BR112021023832A8 BR 112021023832 A8 BR112021023832 A8 BR 112021023832A8 BR 112021023832 A BR112021023832 A BR 112021023832A BR 112021023832 A BR112021023832 A BR 112021023832A BR 112021023832 A8 BR112021023832 A8 BR 112021023832A8
- Authority
- BR
- Brazil
- Prior art keywords
- nitric oxide
- compositions
- generation
- methods
- organic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B21/00—Nitrogen; Compounds thereof
- C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
- C01B21/24—Nitric oxide (NO)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
MÉTODOS E COMPOSIÇÕES PARA GERAÇÃO DE ÓXIDO NÍTRICO E USOS DOS MESMOS. A invenção fornece uma combinação, kit ou composição compreendendo: (i) um ou mais sais de nitrito; (ii) uma fonte de próton compreendendo um ou mais ácidos selecionados de ácidos carboxílicos orgânicos e ácidos orgânicos não carboxílicos redutores; e (iii) um ou mais polióis orgânicos. Na reação do um ou mais sais de nitrito com a fonte de próton na presença do um ou mais polióis orgânicos, a combinação, kit ou composição fornece produtos de reação que incluem óxido nítrico, opcionalmente outros óxidos de nitrogênio e/ou opcionalmente precursores dos mesmos e que são úteis, por exemplo, no tratamento de vários distúrbios.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1907969.8A GB201907969D0 (en) | 2019-06-04 | 2019-06-04 | Methods and compositions for generating nitric oxide and uses thereof |
GB201915280A GB201915280D0 (en) | 2019-10-22 | 2019-10-22 | Methods and compositions for generating nitric oxide and uses thereof |
GBGB2005980.4A GB202005980D0 (en) | 2020-04-23 | 2020-04-23 | Methods and compositions for generating nitric oxide and uses thereof |
PCT/GB2020/051328 WO2020245573A1 (en) | 2019-06-04 | 2020-06-02 | Methods and compositions for generating nitric oxide and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112021023832A2 BR112021023832A2 (pt) | 2022-01-04 |
BR112021023832A8 true BR112021023832A8 (pt) | 2023-02-28 |
Family
ID=71083655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021023832A BR112021023832A8 (pt) | 2019-06-04 | 2020-06-02 | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220370493A1 (pt) |
EP (1) | EP3980373A1 (pt) |
JP (1) | JP2023510661A (pt) |
CN (1) | CN114206325A (pt) |
AU (1) | AU2020286677A1 (pt) |
BR (1) | BR112021023832A8 (pt) |
CA (1) | CA3142101A1 (pt) |
GB (1) | GB2599576B (pt) |
WO (1) | WO2020245573A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10517817B2 (en) | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
GB2610721A (en) * | 2020-04-23 | 2023-03-15 | Thirty Respiratory Ltd | Methods and compositions for treating and combatting tuberculosis |
GB2610722A (en) * | 2020-04-23 | 2023-03-15 | Thirty Respiratory Ltd | Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 |
WO2021256540A1 (ja) * | 2020-06-19 | 2021-12-23 | 第一製網株式会社 | ウイルス不活化製剤 |
GB202215758D0 (en) * | 2022-10-25 | 2022-12-07 | Thirty Holdings Ltd | Implantable medical devices |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826255A (en) | 1972-06-22 | 1974-07-30 | Hudson Oxygen Therapy Sales Co | Intermittent positive pressure breathing manifold |
YU41046B (en) | 1974-08-22 | 1986-10-31 | Schering Ag | Medicine inholating device |
US4130639A (en) | 1977-09-28 | 1978-12-19 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
US4253468A (en) | 1978-08-14 | 1981-03-03 | Steven Lehmbeck | Nebulizer attachment |
US4263907A (en) | 1979-05-14 | 1981-04-28 | Lindsey Joseph W | Respirator nebulizer |
US4510929A (en) | 1982-04-30 | 1985-04-16 | Bordoni Maurice E | Disposable radioactive aerosol inhalation apparatus |
US4649911A (en) | 1983-09-08 | 1987-03-17 | Baylor College Of Medicine | Small particle aerosol generator for treatment of respiratory disease including the lungs |
US4624251A (en) | 1984-09-13 | 1986-11-25 | Riker Laboratories, Inc. | Apparatus for administering a nebulized substance |
NZ241579A (en) | 1991-03-25 | 1994-04-27 | Becton Dickinson Co | Antimicrobial formulations for treating the skin |
US5164740A (en) | 1991-04-24 | 1992-11-17 | Yehuda Ivri | High frequency printing mechanism |
DK0540775T3 (da) | 1991-11-07 | 1997-08-25 | Ritzau Pari Werk Gmbh Paul | Forstøver især til anvendelse i apparater til inhalationsterapi |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
WO1995009605A1 (en) | 1993-10-06 | 1995-04-13 | Henkel Corporation | Improving phenolic disinfectant cleaning compositions with alkylpolyglucoside surfactants |
US6034133A (en) | 1993-11-05 | 2000-03-07 | The University Of Virginia Patents Foundation | Use of a virucidal hand lotion to prevent the spread of rhinovirus colds |
CZ286286B6 (cs) | 1994-02-21 | 2000-03-15 | Aberdeen University | Aplikační forma, sterilizační prostředek, doplňkové krmivo a způsob sterilizace |
GB9804469D0 (en) | 1998-03-02 | 1998-04-29 | Univ Aberdeen | Antiviral composition |
US5681802A (en) | 1994-06-01 | 1997-10-28 | Lever Brothers Company, Division Of Conopco, Inc. | Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness |
US5635462A (en) | 1994-07-08 | 1997-06-03 | Gojo Industries, Inc. | Antimicrobial cleansing compositions |
US5776430A (en) | 1994-11-01 | 1998-07-07 | Calgon Vestal, Inc. | Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
US5702754A (en) | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
WO1996025918A1 (en) | 1995-02-24 | 1996-08-29 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
ZA962455B (en) | 1995-03-31 | 1996-10-02 | B Eugene Guthery | Fast acting and persistent topical antiseptic |
US5586550A (en) | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
US5955408A (en) | 1996-07-10 | 1999-09-21 | Steris Inc. | Triclosan skin wash with enhanced efficacy |
US5906202A (en) | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
US6349719B2 (en) | 1997-02-24 | 2002-02-26 | Aradigm Corporation | Formulation and devices for monitoring the efficacy of the delivery of aerosols |
US6258368B1 (en) | 1997-06-04 | 2001-07-10 | The Procter & Gamble Company | Antimicrobial wipes |
US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
ATE215820T1 (de) | 1997-10-08 | 2002-04-15 | Sepracor Inc | Dosierungsform zur verabreichung von aerosolen |
DK0923957T3 (da) | 1997-11-19 | 2002-02-18 | Microflow Eng Sa | Dyseemne og væskedråbesprøjteindretning til en inhalator egnet til respirationsterapi |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
US6258371B1 (en) | 1998-04-03 | 2001-07-10 | Medtronic Inc | Method for making biocompatible medical article |
US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
WO2000006214A1 (en) | 1998-07-31 | 2000-02-10 | First Water Limited | Bioadhesive compositions and biomedical electrodes containing them |
GB2343122B (en) | 1998-10-26 | 2003-01-08 | Medic Aid Ltd | Improvements in and relating to nebulisers |
US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
US6584971B1 (en) | 1999-01-04 | 2003-07-01 | Medic-Aid Limited | Drug delivery apparatus |
GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
JP2000355667A (ja) | 1999-04-14 | 2000-12-26 | Seiko Epson Corp | カラーインクジェット記録用水系顔料インクセット、カラーインクジェット記録方法、及びカラーインクジェット記録物 |
US6338443B1 (en) | 1999-06-18 | 2002-01-15 | Mercury Enterprises, Inc. | High efficiency medical nebulizer |
US6107261A (en) | 1999-06-23 | 2000-08-22 | The Dial Corporation | Compositions containing a high percent saturation concentration of antibacterial agent |
CA2919286A1 (en) | 2000-04-11 | 2001-10-18 | Trudell Medical International | Respiratory apparatus |
GB0021317D0 (en) | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
GB0022084D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Aberdeen | Treatment of multiply antibiotic-resistant organisms |
US6601581B1 (en) | 2000-11-01 | 2003-08-05 | Advanced Medical Applications, Inc. | Method and device for ultrasound drug delivery |
GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
US7135189B2 (en) | 2001-08-23 | 2006-11-14 | Boston Scientific Scimed, Inc. | Compositions and techniques for localized therapy |
GB0125222D0 (en) | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
US7066356B2 (en) | 2002-08-15 | 2006-06-27 | Ecolab Inc. | Foam soap dispenser for push operation |
JP4738352B2 (ja) | 2004-02-09 | 2011-08-03 | アミュレット ファーマシューティカルズ インコーポレイティッド | 一酸化窒素放出ポリマー |
US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
EP1917047B1 (en) | 2005-07-14 | 2019-09-04 | First Water Limited | Treatment of chronic ulcerous skin lesions |
CN101028229B (zh) | 2006-03-02 | 2012-09-05 | 北京富丽华德生物医药科技有限公司 | 基于一氧化氮的新型化妆品 |
CN101062050A (zh) | 2006-04-29 | 2007-10-31 | 北京尼奥克斯生物科技有限公司 | 一种基于一氧化氮的新型生发产品及其制备方法 |
RU2008152402A (ru) | 2006-05-30 | 2010-07-10 | Дзе Дайл Корпорейшн (Us) | Композиции, обладающие сильным противовирусным действием |
WO2008110872A2 (en) | 2006-06-23 | 2008-09-18 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
GB0700908D0 (en) | 2007-01-17 | 2007-02-28 | First Water Ltd | Inhibition of proteases, particularly in the treatment of chronic ulcerous skin lesions |
GB0700911D0 (en) | 2007-01-17 | 2007-02-28 | First Water Ltd | Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions |
GB0715556D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
US9278157B2 (en) * | 2007-08-09 | 2016-03-08 | Insense Limited | Nitric oxide-generating skin dressings |
JP2011507968A (ja) * | 2007-12-27 | 2011-03-10 | エイヤーズ ファーマシューティカルズ、インク. | エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用 |
US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
JP2011010865A (ja) * | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
EP2575829A4 (en) * | 2010-06-07 | 2014-04-30 | Topical Pharma Ab | KIT FOR THE TREATMENT OF ONYCHOMYCOSIS BY NITRIC OXIDE |
US20130200109A1 (en) | 2012-02-06 | 2013-08-08 | Frank Yang | Foaming soap dispensers and methods |
CN103622917B (zh) | 2012-08-23 | 2017-12-29 | 尼奥克斯(文莱)控股有限公司 | 基于微囊化亚硝酸盐和酸化水凝胶的延时产生一氧化氮的***和方法 |
US10517817B2 (en) * | 2013-05-09 | 2019-12-31 | Syk Technologies, Llc | Deep topical systemic nitric oxide therapy apparatus and method |
GB201309091D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Dressing system |
GB201309092D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
WO2015138406A1 (en) | 2014-03-14 | 2015-09-17 | 12th Man Technologies, Inc. | Treating diseases using nitric oxide releasing solutions |
FI3407900T3 (fi) | 2016-01-27 | 2024-03-21 | Syk Tech Llc | Laitteisto typpioksidin paikalliseksi levittämiseksi ja menetelmiä |
-
2020
- 2020-06-02 JP JP2021572282A patent/JP2023510661A/ja active Pending
- 2020-06-02 GB GB2118473.4A patent/GB2599576B/en active Active
- 2020-06-02 CN CN202080055856.2A patent/CN114206325A/zh active Pending
- 2020-06-02 AU AU2020286677A patent/AU2020286677A1/en active Pending
- 2020-06-02 EP EP20732271.0A patent/EP3980373A1/en active Pending
- 2020-06-02 BR BR112021023832A patent/BR112021023832A8/pt unknown
- 2020-06-02 WO PCT/GB2020/051328 patent/WO2020245573A1/en active Search and Examination
- 2020-06-02 US US17/616,468 patent/US20220370493A1/en active Pending
- 2020-06-02 CA CA3142101A patent/CA3142101A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB2599576A (en) | 2022-04-06 |
US20220370493A1 (en) | 2022-11-24 |
GB2599576B (en) | 2023-09-13 |
EP3980373A1 (en) | 2022-04-13 |
CN114206325A (zh) | 2022-03-18 |
CA3142101A1 (en) | 2020-12-10 |
WO2020245573A1 (en) | 2020-12-10 |
AU2020286677A1 (en) | 2021-12-09 |
BR112021023832A2 (pt) | 2022-01-04 |
JP2023510661A (ja) | 2023-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112021023832A8 (pt) | Métodos e composições para geração de óxido nítrico e usos dos mesmos | |
BR112021023632A2 (pt) | Métodos e composições para gerar óxido nítrico e usos do mesmo para entregar óxido nítrico através do trato respiratório | |
BR112018067442A8 (pt) | Composto, composição farmacêutica, método de inibir a atividade da amina oxidase, método de tratar uma condição e uso de um composto | |
NZ759766A (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
BR112021006392A2 (pt) | moduladores da alfa-1 antitripsina | |
BR112014020021A8 (pt) | Composição, método para melhorar a atividade antimicrobiana de um biocida, e, usos de uma poliamina e de uma composição | |
BR112017008482A2 (pt) | métodos e sistema para suprimir a corrosão das superfícies de aço | |
CL2007003666A1 (es) | Compuestos derivados del acido nicotinico; composicion farmaceutica que comprende a dichos compuestos; combinacion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis, esclerosis multiple, psoriasis, entre otras. | |
BR112018010381A2 (pt) | composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos. | |
BR112014012689A8 (pt) | montagem e método de uso de um cateter e método para administração de uma composição antimicrobiana | |
BR112017015773A2 (pt) | muteína de lipocalina, muteína de hngal, molécula de ácido nucleico, célula hospedeira, método para produzir a muteína de hngal, composição farmacêutica, kit, uso da muteína de hngal, uso da muteína de hngal, método para ligar ang-2 em um indivíduo, método para inibir angiogênese em um indivíduo, método para tratar, prevenir ou melhorar uma doença e método para inibir ou reduzir angiogênese em um indivíduo | |
BR112019024785A2 (pt) | composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso | |
BR112022001341A2 (pt) | Inibidores de enzima | |
BR112019007543A2 (pt) | inibidores de ácido alfa-amino-beta-carboximuconico semialdeido decarboxilase | |
BR112022021454A2 (pt) | Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2 | |
BR112018072339A2 (pt) | tratamento de distúrbios de perda de cabelo com inibidores de jak deuterados | |
BR112018009837A2 (pt) | composição catalítica e composição curável | |
BR112022023013A2 (pt) | Inibidores de mek para tratamento ou prevenção de infecções por coronavírus e/ou de tempestade de citocinas de covid-19 | |
CL2019001746A1 (es) | Amidas aromáticas de ácido carboxílico | |
CO2022000270A2 (es) | Inhibidores de enzimas | |
WO2020247701A3 (en) | Inhibitors of sarm1 | |
BR112022001054A2 (pt) | Inibidores enzimáticos | |
AR101811A1 (es) | Anticuerpo monoclonal humanizado que inhibe la actividad enzimática de la lipasa endotelial vascular | |
BR112015005185A2 (pt) | composição aquosa de revestimento; substrato e método de preparar uma composição aquosa de revestimento | |
BR112022002289A2 (pt) | Composições de curativo líquido e seus usos veterinários |